Drug Type Small molecule drug |
Synonyms AF-14049, AF-15394, AF14049 |
Target |
Action inhibitors |
Mechanism MPI inhibitors(mannose phosphate isomerase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H20Cl2N2O3S |
InChIKeyLMNYCZICCBTEFX-UHFFFAOYSA-N |
CAS Registry215313-41-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Candidiasis | Preclinical | United States | 02 Sep 1998 | |
Mycoses | Discovery | United States | - |